Literature DB >> 29074007

Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.

Raageen Kanjee1, Ravi I Dookeran2, Mathen K Mathen2, Frank A Stockl2, Richard Leicht2.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the diabetic retinopathy (DR) tele-ophthalmology screening program in Manitoba to determine prevalence and incidence of DR, as well as to estimate the program's cost-effectiveness.
DESIGN: Retrospective chart review. PARTICIPANTS: A total of 4676 patients with type 2 diabetes examined 9334 times from 2007 to 2013.
METHODS: Focused ophthalmic histories were recorded and examinations were performed by trained nurses, including visual acuities, intraocular pressure, and mydriatic 7 standard field stereoscopic fundus photography. Images were evaluated by retinal specialists according to the Early Treatment of Diabetic Retinopathy Study criteria. DR prevalence and incidence were then calculated during the study period. Cost-effectiveness was estimated by comparing the cost of running the tele-ophthalmology program compared with the cost of screening the same volume of patients in-office.
RESULTS: The average prevalence of any DR in each year was 25.1%. The cumulative incidence of DR across 6 years was 17.1% (95% CI, 15.4%-18.7%). The average savings per tele-ophthalmology examination was $1007.
CONCLUSIONS: DR is highly prevalent among the studied population. Tele-ophthalmology provides a cost-effective means of monitoring patients as well as identifying new or treatable disease.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2017        PMID: 29074007     DOI: 10.1016/j.jcjo.2017.09.022

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  8 in total

1.  Telehealth Screening for Diabetic Retinopathy: Economic Modeling Reveals Cost Savings.

Authors:  Delaney M Curran; Brian Y Kim; Natasha Withers; Donald S Shepard; Christopher J Brady
Journal:  Telemed J E Health       Date:  2022-01-24       Impact factor: 5.033

2.  Celastrol inhibits the proliferation and angiogenesis of high glucose-induced human retinal endothelial cells.

Authors:  Jian Fang; Xiaoke Chang
Journal:  Biomed Eng Online       Date:  2021-06-30       Impact factor: 2.819

Review 3.  A Systematic Review of Current Teleophthalmology Services in New Zealand Compared to the Four Comparable Countries of the United Kingdom, Australia, United States of America (USA) and Canada.

Authors:  Liam Walsh; Sheng Chiong Hong; Renoh Johnson Chalakkal; Kelechi C Ogbuehi
Journal:  Clin Ophthalmol       Date:  2021-10-04

4.  Prevalence and risk factors of diabetic retinopathy among Chinese adults with type 2 diabetes in a suburb of Shanghai, China.

Authors:  Huiling Tan; Xin Wang; Kaiyou Ye; Jianmin Lin; E Song; Lihua Gong
Journal:  PLoS One       Date:  2022-10-04       Impact factor: 3.752

Review 5.  The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy.

Authors:  Janusz Pieczynski; Patrycja Kuklo; Andrzej Grzybowski
Journal:  Ophthalmol Ther       Date:  2021-06-22

Review 6.  Corneal Vibrations during Intraocular Pressure Measurement with an Air-Puff Method.

Authors:  Robert Koprowski; Sławomir Wilczyński
Journal:  J Healthc Eng       Date:  2018-02-11       Impact factor: 2.682

Review 7.  Fundamental principles of an effective diabetic retinopathy screening program.

Authors:  Paolo Lanzetta; Valentina Sarao; Peter H Scanlon; Jane Barratt; Massimo Porta; Francesco Bandello; Anat Loewenstein
Journal:  Acta Diabetol       Date:  2020-03-28       Impact factor: 4.280

Review 8.  Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.

Authors:  Daniel Avidor; Anat Loewenstein; Michael Waisbourd; Amir Nutman
Journal:  Cost Eff Resour Alloc       Date:  2020-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.